Johnson & Johnson Reports 96-Week Data Showing Lon...
Category : Clinical Trial Update 29 October 2025Johnson & Johnson (J&J) has announced new 96-week data from the long-term extensions (LTE) o...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Johnson & Johnson (J&J) has announced new 96-week data from the long-term extensions (LTE) o...
Jupiter Endovascular, Inc., a medical technology company developing next-generation endovascular int...
Philips has announced the expansion of its collaboration with Nicolab, a pioneer in AI-powered strok...
Evotec SE, a life science company focused on accelerating drug discovery and development, announced...
Eli Lilly and Company and Incyte have reported new one-year data from the Phase 3 BRAVE-AA-PEDS stud...